{
  "id": 21036712,
  "title": "New drug combination shrinks tumors in most pancreatic cancer patients",
  "url": "https://urgent.news/2026/11/21/new-drug-combination-shrinks-tumors-in-most-pancreatic-cancer-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-21T11:17:02.000Z",
  "source": {
    "name": "Daily Times",
    "slug": "daily-times",
    "url": "https://dailytimes.com.pk/1584874/new-drug-combination-shrinks-tumors-in-most-pancreatic-cancer-patients/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new oral medication combined with standard chemotherapy shrank tumors in over 60 percent of advanced pancreatic cancer patients. Researchers presented these promising phase 1/2 clinical trial results at the EORTC-NCI-AACR Symposium in Barcelona on Friday. Specifically, the study tested a daily pill called daraxonrasib alongside two standard intravenous chemotherapy drugs, gemcitabine and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}